P. Cantor

2.2k total citations · 1 hit paper
44 papers, 1.7k citations indexed

About

P. Cantor is a scholar working on Cellular and Molecular Neuroscience, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P. Cantor has authored 44 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 18 papers in Surgery and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P. Cantor's work include Neuropeptides and Animal Physiology (28 papers), Diabetes Treatment and Management (10 papers) and Neuroendocrine Tumor Research Advances (9 papers). P. Cantor is often cited by papers focused on Neuropeptides and Animal Physiology (28 papers), Diabetes Treatment and Management (10 papers) and Neuroendocrine Tumor Research Advances (9 papers). P. Cantor collaborates with scholars based in Denmark, Sweden and Germany. P. Cantor's co-authors include Laurence Klotz, Tine Kold Olesen, Fritz H. Schröder, Neal D. Shore, L Boccon-Gibod, Bo‐Eric Persson, Jens F. Rehfeld, W. Creutzfeldt, Ole Olsen and H. Worning and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

P. Cantor

44 papers receiving 1.6k citations

Hit Papers

The efficacy and safety of degarelix: a 12‐month, compara... 2008 2026 2014 2020 2008 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Cantor Denmark 20 562 502 490 428 426 44 1.7k
Stig Ingemansson Sweden 25 487 0.9× 227 0.5× 437 0.9× 147 0.3× 423 1.0× 58 1.5k
Anthony L. Mulloy United States 16 462 0.8× 96 0.2× 191 0.4× 64 0.1× 251 0.6× 29 1.1k
Morten Wøjdemann Denmark 17 579 1.0× 168 0.3× 579 1.2× 156 0.4× 289 0.7× 31 1.4k
A P Savage United Kingdom 16 164 0.3× 335 0.7× 455 0.9× 123 0.3× 271 0.6× 27 1.2k
Kristine Juul Hare Denmark 20 701 1.2× 85 0.2× 588 1.2× 142 0.3× 214 0.5× 40 1.4k
Jean‐Marie Villette France 20 523 0.9× 61 0.1× 116 0.2× 268 0.6× 142 0.3× 38 1.4k
C N Mallinson United Kingdom 16 415 0.7× 223 0.4× 577 1.2× 148 0.3× 379 0.9× 26 1.5k
Thomas P. Conlon United States 15 247 0.4× 642 1.3× 386 0.8× 110 0.3× 231 0.5× 18 1.3k
Fischer Ja Switzerland 17 131 0.2× 260 0.5× 106 0.2× 40 0.1× 122 0.3× 50 803
Herschel L. Estep United States 12 373 0.7× 48 0.1× 221 0.5× 132 0.3× 92 0.2× 15 1.2k

Countries citing papers authored by P. Cantor

Since Specialization
Citations

This map shows the geographic impact of P. Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Cantor more than expected).

Fields of papers citing papers by P. Cantor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Cantor. The network helps show where P. Cantor may publish in the future.

Co-authorship network of co-authors of P. Cantor

This figure shows the co-authorship network connecting the top 25 collaborators of P. Cantor. A scholar is included among the top collaborators of P. Cantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Cantor. P. Cantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klotz, Laurence, L Boccon-Gibod, Neal D. Shore, et al.. (2008). The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer. British Journal of Urology. 102(11). 1531–1538. 447 indexed citations breakdown →
2.
Malesci, Alberto, et al.. (1995). No Effect of Long-Term Treatment with Pancreatic Extract on Recurrent Abdominal Pain in Patients with Chronic Pancreatitis. Scandinavian Journal of Gastroenterology. 30(4). 392–398. 60 indexed citations
3.
Ainsworth, Mark, P. Svendsen, Lars Ladegaard, et al.. (1992). Relative Importance of Pancreatic, Hepatic, and Mucosal Bicarbonate in Duodenal Neutralization of Acid in Anaesthetized Pigs. Scandinavian Journal of Gastroenterology. 27(5). 343–349. 8 indexed citations
5.
Cantor, P., et al.. (1992). The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Gastroenterology. 102(5). 1742–1751. 40 indexed citations
6.
Lundell, Lars, et al.. (1991). Factors Influencing the Release of Cholecystokinin Induced by Gastrin-Releasing Peptide in Man. Scandinavian Journal of Gastroenterology. 26(5). 544–550. 7 indexed citations
7.
Rehfeld, Jens F., Linda Bardram, P. Cantor, et al.. (1991). The Expression OF Peptide Hormones in Normal Cells and Tumour Cells. Acta Oncologica. 30(4). 429–433. 1 indexed citations
8.
Cantor, P., Ole Olsen, B. J. Gertz, Ida Gjørup, & H. Worning. (1991). Inhibition of Cholecystokinin-Stimulated Pancreaticobiliary Output in Man by the Cholecystokinin Receptor Antagonist MK-329. Scandinavian Journal of Gastroenterology. 26(6). 627–637. 22 indexed citations
10.
Cantor, P., et al.. (1990). Does Sulfation of Gastrin Influence Gastric Acid Secretion in Man?. Scandinavian Journal of Gastroenterology. 25(7). 739–745. 16 indexed citations
11.
Cantor, P.. (1989). Cholecystokinin in Plasma. Digestion. 42(4). 181–201. 49 indexed citations
12.
Rehfeld, Jens F., Linda Bardram, P. Cantor, et al.. (1989). Peptide Hormone Expression and Precursor Processing. Acta Oncologica. 28(3). 315–318. 9 indexed citations
13.
Nauck, Michael A., Wolfgang E. Schmidt, R. Ebert, et al.. (1989). Insulinotropic Properties of Synthetic Human Gastric Inhibitory Polypeptide in Man: Interactions with Glucose, Phenylalanine, and Cholecystokinin-8. The Journal of Clinical Endocrinology & Metabolism. 69(3). 654–662. 91 indexed citations
14.
Olsen, Ole, Ove B. Schaffalitzky de Muckadell, & P. Cantor. (1989). Fat and Pancreatic Secretion. Scandinavian Journal of Gastroenterology. 24(1). 74–80. 22 indexed citations
15.
Rehfeld, Jens F., Linda Bardram, P. Cantor, Linda Hilsted, & Thue W. Schwartz. (1988). Cell-specific processing of pro-cholecystokinin and pro-gastrin. Biochimie. 70(1). 25–31. 24 indexed citations
16.
Olsen, Ole, Ove B. Schaffalitzky de Muckadell, P. Cantor, et al.. (1988). Effect of Trypsin on the Hormonal Regulation of the Fat-Stimulated Human Exocrine Pancreas. Scandinavian Journal of Gastroenterology. 23(7). 875–881. 12 indexed citations
17.
18.
Nauck, Michael A., et al.. (1988). Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man. Diabetologia. 31(5). 271–280. 23 indexed citations
19.
Rehfeld, Jens F., et al.. (1987). Cholecystokinin Secretion in Pregnancy. Scandinavian Journal of Gastroenterology. 22(6). 687–690. 10 indexed citations
20.
Olsen, Ole, Ove B. Schaffalitzky de Muckadell, & P. Cantor. (1987). Plasma Secretin, Plasma Cholecystokinin, Pancreaticobiliary Secretion, and Fat Absorption: Effect of Duodenal Osmolality and Polysorbate 80. Scandinavian Journal of Gastroenterology. 22(9). 1109–1114. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026